Candel Therapeutics Inc (CADL)
Candel Therapeutics Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights
Lixte Biotechnology Holdings Inc. (LIXTW)
24/7 Market News: LIXTE Biotech Advances Precision Oncology Pipeline with Multiple Phase 1B/2 Trial Readouts Expected in 2H 2025
Lixte Biotechnology Holdings Inc. (LIXT)
24/7 Market News: LIXTE Biotech Advances Precision Oncology Pipeline with Multiple Phase 1B/2 Trial Readouts Expected in 2H 2025
Outlook Therapeutics Inc. (OTLK)
Outlook Therapeutics Reports Financial Results for Third Quarter Fiscal Year 2025 and Provides Corporate Update
Arcutis Biotherapeutics (ARQT)
CARGO Therapeutics Inc (CRGX)
Clene Inc. (CLNN)
Axsome Therapeutics Inc (AXSM)
Chemomab Therapeutics Ltd. (CMMB)
Chemomab Therapeutics Announces Second Quarter 2025 Financial Results and Provides Corporate Update
PAVmed Inc (PAVMZ)
PAVmed Provides Business Update and Reports Second Quarter 2025 Financial Results
Scholar Rock Holding Corp (SRRK)
Pivotal SAPPHIRE Trial Data Published in The Lancet Neurology: Apitegromab Demonstrated Significant Motor Function Gains for Children and Adults with SMA on SMN-Targeted Treatment
Chemomab Therapeutics Ltd. (CMMB)
IMARA Inc. (the company became a subdivision of the company Enliven Therapeutics Inc (ELVN)) (IMRA)
Cocrystal Pharma Inc. (COCP)
Galectin Therapeutics Inc. (GALT)
Galectin Therapeutics Reports Financial Results for the Quarter Ended June 30, 2025 and Provides Business Update